Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yinmeng Yang
Il-6 Is Non-Essential to Murine CD19 CAR Efficacy, but Can Mediate Acute GVHD Following Allogeneic BMT With CAR T Cell Infusion
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Toxicities of CD19 CAR-T Cell Immunotherapy
American Journal of Hematology
Hematology
Allogeneic CAR T Cell Therapies for Leukemia - R1
American Journal of Hematology
Hematology
Outcomes of Patients With Large B‐Cell Lymphomas and Progressive Disease Following CD19‐Specific CAR T‐Cell Therapy
American Journal of Hematology
Hematology
Safety of Allogeneic Hematopoietic Cell Transplant in Adults After Cd19 Targeted Chimeric Antigen Receptor-Modified T-Cell (Car-T) Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Efficacy and Safety of Humanized Anti-Cd19-Car-T Therapy Following Intensive Lymphodepleting Chemotherapy for Refractory/Relapsed B Acute Lymphoblastic Leukaemia
British Journal of Haematology
Hematology
CAR-T Cells Beyond CD19, UnCAR-Ted Territory
American Journal of Hematology
Hematology
Cd19/Cd20-Redirected Bispecific Car T Cell Treatment in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
T-Rapa6 and T-Rapa12 Cells Differentially Mediate Acute GVHD After Low-Intensity Allogeneic HCT
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
CAR-T Cells and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Immunotherapy
Oncology
Allergy
Immunology
